UKCGG leaflets and guidelines

NEW! UKCGG/FGG BSGM Guidance - Prenatal diagnosis and pre-implantation genetic testing for germline cancer susceptibility gene variants

UKCGG/FGG BSGM Guidance - Prenatal diagnosis and pre-implantation genetic testing for germline cancer susceptibility gene variants
UKCGG/FGG BSGM Patient Leaflet: Reproductive Options for Cancer Susceptibility Gene Variants
Genetic Counselling framework for couples exploring reproductive options for cancer susceptibility gene variants

NEW! Management Guidelines for BRIP1 germline pathogenic variant carriers

Management Guidelines for BRIP1 germline pathogenic variant carriers

NEW! UKCGG Management Guidelines for PALB2 germline pathogenic variant carriers

NEW! Updated UKCGG Management Guidelines for BRCA1/BRCA2 germline pathogenic variant carriers (Version 2)

UKCGG Management Guidelines for FLCN germline pathogenic variant carriers

UKCGG Management Guidelines for FLCN germline pathogenic variant carriers

UKCGG Management Guidelines for FH germline pathogenic variant carriers

UKCGG Management Guidelines for FH germline pathogenic variant carriers

UKCGG Management Guidelines for RAD51C/RAD51D germline pathogenic variant carriers

Management of carriers of pathogenic germline variants in "moderate risk" ovarian cancer susceptibility genes

Click on the links to download the UKCGG guidelines for the management of carriers of pathogenic germline variants in RAD51C and RAD51D.

You may also be interested in reading about the national consensus meeting we held in October 2021 to determine best practice in testing of these and other "moderate risk" ovarian cancer susceptibility genes, and management of carriers in whom variants in such genes are identified. For information about this and other UKCGG consensus meetings click here.

A copy of the manuscript arising from the meeting is available at the link here above.